Atish Patel

Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models

Amit K. Tiwari, Kamlesh Sodani, Chun-ling Dai et al. · Cancer Letters · 2012 · 140 citations

Medicine, Oncology, Pharmacology +11

GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance

Kamlesh Sodani, Amit K. Tiwari, Satyakam Singh et al. · Biochemical Pharmacology · 2012 · 61 citations · Full text

Medicine, Oncology, Pharmacology +15

Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1

Yi‐Jun Wang, Rishil J. Kathawala, Yunkai Zhang et al. · Biochemical Pharmacology · 2014 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter <scp>MRP1</scp>

Hui Zhang, Atish Patel, Shaolin Ma et al. · British Journal of Pharmacology · 2014 · 52 citations · Full text

Medicine, Oncology, Pharmacology +17

PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR

Nagaraju Anreddy, Atish Patel, Kamlesh Sodani et al. · Acta Pharmaceutica Sinica B · 2014 · 52 citations · Full text

Medicine, Oncology, Pharmacology +14